Quick Answer
TriSalus Life Sciences, Inc. reported Total Assets of $35.33 million for fiscal year 2025.
TriSalus Life Sciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $35.33M | +47.4% |
| 2024 | $23.97M | -2.5% |
| 2023 | $24.60M | +11.8% |
| 2022 | $22.00M | -91.2% |
| 2021 | $250.53M | -0.6% |
| 2020 | $252.01M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $36.46M | +32.7% | -11.7% |
| June 30, 2025 | $41.32M | +27.4% | +44.3% |
| March 31, 2025 | $28.62M | +60.0% | +19.4% |
| December 31, 2024 | $23.97M | -2.5% | -12.8% |
| September 30, 2024 | $27.48M | -18.1% | -15.3% |
| June 30, 2024 | $32.43M | +165.0% | +81.3% |
| March 31, 2024 | $17.89M | -12.8% | -27.3% |
| December 31, 2023 | $24.60M | +11.8% | -26.7% |
- TriSalus Life Sciences, Inc. showed an increase of +47.4% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, TriSalus Life Sciences, Inc.’s total assets has declined by 86.0% (from $252.01 million to $35.33 million).
- The most recent figure is from TriSalus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: